Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
Maurizio Benucci, Arianna Damiani, Gianfranco Giannasi, Francesca Li Gobbi, Luca Quartuccio, Valentina Grossi, María Infantino, Mariangela Manfredi
Topics & Concepts
MedicineEpidemiologyInternal medicineRheumatologyIncidence (geometry)HydroxychloroquineSerologyPopulationPneumoniaPrednisoneCoronavirus disease 2019 (COVID-19)DiseaseImmunologyInfectious disease (medical specialty)AntibodyEnvironmental healthOpticsPhysicsDermatological and COVID-19 studiesCOVID-19 Clinical Research StudiesStreptococcal Infections and Treatments